Inactivation of dengue, chikungunya, and Ross River viruses in platelet concentrates after treatment with ultraviolet C light.
Identifieur interne : 003209 ( Ncbi/Merge ); précédent : 003208; suivant : 003210Inactivation of dengue, chikungunya, and Ross River viruses in platelet concentrates after treatment with ultraviolet C light.
Auteurs : Helen M. Faddy ; Jesse J. Fryk ; Natalie A. Prow ; Daniel Watterson ; Paul R. Young ; Roy A. Hall ; Frank Tolksdorf [Allemagne] ; Chryslain Sumian [France] ; Ute Gravemann [Allemagne] ; Axel Seltsam [Allemagne] ; Denese C. MarksSource :
- Transfusion [ 1537-2995 ] ; 2016.
Descripteurs français
- KwdFr :
- Humains, Inactivation virale (effets des radiations), Limite de détection, Plaquettes (virologie), Rayons ultraviolets, Relation dose-effet des radiations, Sécurité transfusionnelle (), Transfusion de plaquettes (effets indésirables), Transfusion de plaquettes (normes), Virus de la dengue (effets des radiations), Virus de la rivière Ross (effets des radiations), Virus du chikungunya (effets des radiations), Virus à ARN (effets des radiations).
- MESH :
- effets des radiations : Inactivation virale, Virus de la dengue, Virus de la rivière Ross, Virus du chikungunya, Virus à ARN.
- effets indésirables : Transfusion de plaquettes.
- normes : Transfusion de plaquettes.
- virologie : Plaquettes.
- Humains, Limite de détection, Rayons ultraviolets, Relation dose-effet des radiations, Sécurité transfusionnelle.
English descriptors
- KwdEn :
- Blood Platelets (virology), Blood Safety (methods), Chikungunya virus (radiation effects), Dengue Virus (radiation effects), Dose-Response Relationship, Radiation, Humans, Limit of Detection, Platelet Transfusion (adverse effects), Platelet Transfusion (standards), RNA Viruses (radiation effects), Ross River virus (radiation effects), Ultraviolet Rays, Virus Inactivation (radiation effects).
- MESH :
- adverse effects : Platelet Transfusion.
- methods : Blood Safety.
- radiation effects : Chikungunya virus, Dengue Virus, RNA Viruses, Ross River virus, Virus Inactivation.
- standards : Platelet Transfusion.
- virology : Blood Platelets.
- Dose-Response Relationship, Radiation, Humans, Limit of Detection, Ultraviolet Rays.
Abstract
Arboviruses, including dengue (DENV 1-4), chikungunya (CHIKV), and Ross River (RRV), are emerging viruses that are a risk for transfusion safety globally. An approach for managing this risk is pathogen inactivation, such as the THERAFLEX UV-Platelets system. We investigated the ability of this system to inactivate the above mentioned arboviruses.
DOI: 10.1111/trf.13519
PubMed: 26926832
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001D46
- to stream PubMed, to step Curation: 001D22
- to stream PubMed, to step Checkpoint: 001D22
Links to Exploration step
pubmed:26926832Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Inactivation of dengue, chikungunya, and Ross River viruses in platelet concentrates after treatment with ultraviolet C light.</title><author><name sortKey="Faddy, Helen M" sort="Faddy, Helen M" uniqKey="Faddy H" first="Helen M" last="Faddy">Helen M. Faddy</name><affiliation><nlm:affiliation>Research and Development, Australian Red Cross Blood Service.</nlm:affiliation><wicri:noCountry code="subField">Australian Red Cross Blood Service</wicri:noCountry></affiliation></author><author><name sortKey="Fryk, Jesse J" sort="Fryk, Jesse J" uniqKey="Fryk J" first="Jesse J" last="Fryk">Jesse J. Fryk</name><affiliation><nlm:affiliation>Research and Development, Australian Red Cross Blood Service.</nlm:affiliation><wicri:noCountry code="subField">Australian Red Cross Blood Service</wicri:noCountry></affiliation></author><author><name sortKey="Prow, Natalie A" sort="Prow, Natalie A" uniqKey="Prow N" first="Natalie A" last="Prow">Natalie A. Prow</name><affiliation><nlm:affiliation>Australian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland.</nlm:affiliation><wicri:noCountry code="subField">University of Queensland</wicri:noCountry></affiliation></author><author><name sortKey="Watterson, Daniel" sort="Watterson, Daniel" uniqKey="Watterson D" first="Daniel" last="Watterson">Daniel Watterson</name><affiliation><nlm:affiliation>Australian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland.</nlm:affiliation><wicri:noCountry code="subField">University of Queensland</wicri:noCountry></affiliation></author><author><name sortKey="Young, Paul R" sort="Young, Paul R" uniqKey="Young P" first="Paul R" last="Young">Paul R. Young</name><affiliation><nlm:affiliation>Australian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland.</nlm:affiliation><wicri:noCountry code="subField">University of Queensland</wicri:noCountry></affiliation></author><author><name sortKey="Hall, Roy A" sort="Hall, Roy A" uniqKey="Hall R" first="Roy A" last="Hall">Roy A. Hall</name><affiliation><nlm:affiliation>Australian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland.</nlm:affiliation><wicri:noCountry code="subField">University of Queensland</wicri:noCountry></affiliation></author><author><name sortKey="Tolksdorf, Frank" sort="Tolksdorf, Frank" uniqKey="Tolksdorf F" first="Frank" last="Tolksdorf">Frank Tolksdorf</name><affiliation wicri:level="1"><nlm:affiliation>MacoPharma International GmbH, Langen, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>MacoPharma International GmbH, Langen</wicri:regionArea><wicri:noRegion>Langen</wicri:noRegion><wicri:noRegion>Langen</wicri:noRegion><wicri:noRegion>Langen</wicri:noRegion></affiliation></author><author><name sortKey="Sumian, Chryslain" sort="Sumian, Chryslain" uniqKey="Sumian C" first="Chryslain" last="Sumian">Chryslain Sumian</name><affiliation wicri:level="1"><nlm:affiliation>MacoPharma, Tourcoing, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>MacoPharma, Tourcoing</wicri:regionArea><wicri:noRegion>Tourcoing</wicri:noRegion><wicri:noRegion>Tourcoing</wicri:noRegion></affiliation></author><author><name sortKey="Gravemann, Ute" sort="Gravemann, Ute" uniqKey="Gravemann U" first="Ute" last="Gravemann">Ute Gravemann</name><affiliation wicri:level="1"><nlm:affiliation>German Red Cross Blood Service NSTOB, Springe, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>German Red Cross Blood Service NSTOB, Springe</wicri:regionArea><wicri:noRegion>Springe</wicri:noRegion><wicri:noRegion>Springe</wicri:noRegion><wicri:noRegion>Springe</wicri:noRegion></affiliation></author><author><name sortKey="Seltsam, Axel" sort="Seltsam, Axel" uniqKey="Seltsam A" first="Axel" last="Seltsam">Axel Seltsam</name><affiliation wicri:level="1"><nlm:affiliation>German Red Cross Blood Service NSTOB, Springe, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>German Red Cross Blood Service NSTOB, Springe</wicri:regionArea><wicri:noRegion>Springe</wicri:noRegion><wicri:noRegion>Springe</wicri:noRegion><wicri:noRegion>Springe</wicri:noRegion></affiliation></author><author><name sortKey="Marks, Denese C" sort="Marks, Denese C" uniqKey="Marks D" first="Denese C" last="Marks">Denese C. Marks</name><affiliation><nlm:affiliation>Research and Development, Australian Red Cross Blood Service.</nlm:affiliation><wicri:noCountry code="subField">Australian Red Cross Blood Service</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26926832</idno><idno type="pmid">26926832</idno><idno type="doi">10.1111/trf.13519</idno><idno type="wicri:Area/PubMed/Corpus">001D46</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001D46</idno><idno type="wicri:Area/PubMed/Curation">001D22</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001D22</idno><idno type="wicri:Area/PubMed/Checkpoint">001D22</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001D22</idno><idno type="wicri:Area/Ncbi/Merge">003209</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Inactivation of dengue, chikungunya, and Ross River viruses in platelet concentrates after treatment with ultraviolet C light.</title><author><name sortKey="Faddy, Helen M" sort="Faddy, Helen M" uniqKey="Faddy H" first="Helen M" last="Faddy">Helen M. Faddy</name><affiliation><nlm:affiliation>Research and Development, Australian Red Cross Blood Service.</nlm:affiliation><wicri:noCountry code="subField">Australian Red Cross Blood Service</wicri:noCountry></affiliation></author><author><name sortKey="Fryk, Jesse J" sort="Fryk, Jesse J" uniqKey="Fryk J" first="Jesse J" last="Fryk">Jesse J. Fryk</name><affiliation><nlm:affiliation>Research and Development, Australian Red Cross Blood Service.</nlm:affiliation><wicri:noCountry code="subField">Australian Red Cross Blood Service</wicri:noCountry></affiliation></author><author><name sortKey="Prow, Natalie A" sort="Prow, Natalie A" uniqKey="Prow N" first="Natalie A" last="Prow">Natalie A. Prow</name><affiliation><nlm:affiliation>Australian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland.</nlm:affiliation><wicri:noCountry code="subField">University of Queensland</wicri:noCountry></affiliation></author><author><name sortKey="Watterson, Daniel" sort="Watterson, Daniel" uniqKey="Watterson D" first="Daniel" last="Watterson">Daniel Watterson</name><affiliation><nlm:affiliation>Australian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland.</nlm:affiliation><wicri:noCountry code="subField">University of Queensland</wicri:noCountry></affiliation></author><author><name sortKey="Young, Paul R" sort="Young, Paul R" uniqKey="Young P" first="Paul R" last="Young">Paul R. Young</name><affiliation><nlm:affiliation>Australian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland.</nlm:affiliation><wicri:noCountry code="subField">University of Queensland</wicri:noCountry></affiliation></author><author><name sortKey="Hall, Roy A" sort="Hall, Roy A" uniqKey="Hall R" first="Roy A" last="Hall">Roy A. Hall</name><affiliation><nlm:affiliation>Australian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland.</nlm:affiliation><wicri:noCountry code="subField">University of Queensland</wicri:noCountry></affiliation></author><author><name sortKey="Tolksdorf, Frank" sort="Tolksdorf, Frank" uniqKey="Tolksdorf F" first="Frank" last="Tolksdorf">Frank Tolksdorf</name><affiliation wicri:level="1"><nlm:affiliation>MacoPharma International GmbH, Langen, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>MacoPharma International GmbH, Langen</wicri:regionArea><wicri:noRegion>Langen</wicri:noRegion><wicri:noRegion>Langen</wicri:noRegion><wicri:noRegion>Langen</wicri:noRegion></affiliation></author><author><name sortKey="Sumian, Chryslain" sort="Sumian, Chryslain" uniqKey="Sumian C" first="Chryslain" last="Sumian">Chryslain Sumian</name><affiliation wicri:level="1"><nlm:affiliation>MacoPharma, Tourcoing, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>MacoPharma, Tourcoing</wicri:regionArea><wicri:noRegion>Tourcoing</wicri:noRegion><wicri:noRegion>Tourcoing</wicri:noRegion></affiliation></author><author><name sortKey="Gravemann, Ute" sort="Gravemann, Ute" uniqKey="Gravemann U" first="Ute" last="Gravemann">Ute Gravemann</name><affiliation wicri:level="1"><nlm:affiliation>German Red Cross Blood Service NSTOB, Springe, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>German Red Cross Blood Service NSTOB, Springe</wicri:regionArea><wicri:noRegion>Springe</wicri:noRegion><wicri:noRegion>Springe</wicri:noRegion><wicri:noRegion>Springe</wicri:noRegion></affiliation></author><author><name sortKey="Seltsam, Axel" sort="Seltsam, Axel" uniqKey="Seltsam A" first="Axel" last="Seltsam">Axel Seltsam</name><affiliation wicri:level="1"><nlm:affiliation>German Red Cross Blood Service NSTOB, Springe, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>German Red Cross Blood Service NSTOB, Springe</wicri:regionArea><wicri:noRegion>Springe</wicri:noRegion><wicri:noRegion>Springe</wicri:noRegion><wicri:noRegion>Springe</wicri:noRegion></affiliation></author><author><name sortKey="Marks, Denese C" sort="Marks, Denese C" uniqKey="Marks D" first="Denese C" last="Marks">Denese C. Marks</name><affiliation><nlm:affiliation>Research and Development, Australian Red Cross Blood Service.</nlm:affiliation><wicri:noCountry code="subField">Australian Red Cross Blood Service</wicri:noCountry></affiliation></author></analytic><series><title level="j">Transfusion</title><idno type="eISSN">1537-2995</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Blood Platelets (virology)</term><term>Blood Safety (methods)</term><term>Chikungunya virus (radiation effects)</term><term>Dengue Virus (radiation effects)</term><term>Dose-Response Relationship, Radiation</term><term>Humans</term><term>Limit of Detection</term><term>Platelet Transfusion (adverse effects)</term><term>Platelet Transfusion (standards)</term><term>RNA Viruses (radiation effects)</term><term>Ross River virus (radiation effects)</term><term>Ultraviolet Rays</term><term>Virus Inactivation (radiation effects)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Humains</term><term>Inactivation virale (effets des radiations)</term><term>Limite de détection</term><term>Plaquettes (virologie)</term><term>Rayons ultraviolets</term><term>Relation dose-effet des radiations</term><term>Sécurité transfusionnelle ()</term><term>Transfusion de plaquettes (effets indésirables)</term><term>Transfusion de plaquettes (normes)</term><term>Virus de la dengue (effets des radiations)</term><term>Virus de la rivière Ross (effets des radiations)</term><term>Virus du chikungunya (effets des radiations)</term><term>Virus à ARN (effets des radiations)</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Platelet Transfusion</term></keywords><keywords scheme="MESH" qualifier="effets des radiations" xml:lang="fr"><term>Inactivation virale</term><term>Virus de la dengue</term><term>Virus de la rivière Ross</term><term>Virus du chikungunya</term><term>Virus à ARN</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Transfusion de plaquettes</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Blood Safety</term></keywords><keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Transfusion de plaquettes</term></keywords><keywords scheme="MESH" qualifier="radiation effects" xml:lang="en"><term>Chikungunya virus</term><term>Dengue Virus</term><term>RNA Viruses</term><term>Ross River virus</term><term>Virus Inactivation</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Platelet Transfusion</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Plaquettes</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Blood Platelets</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Dose-Response Relationship, Radiation</term><term>Humans</term><term>Limit of Detection</term><term>Ultraviolet Rays</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Limite de détection</term><term>Rayons ultraviolets</term><term>Relation dose-effet des radiations</term><term>Sécurité transfusionnelle</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Arboviruses, including dengue (DENV 1-4), chikungunya (CHIKV), and Ross River (RRV), are emerging viruses that are a risk for transfusion safety globally. An approach for managing this risk is pathogen inactivation, such as the THERAFLEX UV-Platelets system. We investigated the ability of this system to inactivate the above mentioned arboviruses.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26926832</PMID><DateCreated><Year>2016</Year><Month>06</Month><Day>14</Day></DateCreated><DateCompleted><Year>2017</Year><Month>06</Month><Day>22</Day></DateCompleted><DateRevised><Year>2017</Year><Month>06</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1537-2995</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>6 Pt 2</Issue><PubDate><Year>2016</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Transfusion</Title><ISOAbbreviation>Transfusion</ISOAbbreviation></Journal><ArticleTitle>Inactivation of dengue, chikungunya, and Ross River viruses in platelet concentrates after treatment with ultraviolet C light.</ArticleTitle><Pagination><MedlinePgn>1548-55</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/trf.13519</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Arboviruses, including dengue (DENV 1-4), chikungunya (CHIKV), and Ross River (RRV), are emerging viruses that are a risk for transfusion safety globally. An approach for managing this risk is pathogen inactivation, such as the THERAFLEX UV-Platelets system. We investigated the ability of this system to inactivate the above mentioned arboviruses.</AbstractText><AbstractText Label="STUDY DESIGN AND METHODS" NlmCategory="METHODS">DENV 1-4, CHIKV, or RRV were spiked into buffy coat (BC)-derived platelet (PLT) concentrates in additive solution and treated with the THERAFLEX UV-Platelets system at the following doses: 0.05, 0.1, 0.15, and 0.2 J/cm(2) (standard dose). Pre- and posttreatment samples were taken for each dose, and the level of viral infectivity was determined.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">At the standard ultraviolet C (UVC) dose (0.2 J/cm(2) ), viral inactivation of at least 4.43, 6.34, and 5.13 log or more, was observed for DENV 1-4, CHIKV, and RRV, respectively. A dose dependency in viral inactivation was observed with increasing UVC doses.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study has shown that DENV, CHIKV, and RRV, spiked into BC-derived PLT concentrates, were inactivated by the THERAFLEX UV-Platelets system to the limit of detection of our assay, suggesting that this system could contribute to the safety of PLT concentrates with respect to these emerging arboviruses.</AbstractText><CopyrightInformation>© 2016 AABB.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Faddy</LastName><ForeName>Helen M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Research and Development, Australian Red Cross Blood Service.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fryk</LastName><ForeName>Jesse J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Research and Development, Australian Red Cross Blood Service.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prow</LastName><ForeName>Natalie A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Australian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watterson</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Australian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Paul R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Australian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Roy A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Australian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tolksdorf</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>MacoPharma International GmbH, Langen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sumian</LastName><ForeName>Chryslain</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>MacoPharma, Tourcoing, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gravemann</LastName><ForeName>Ute</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>German Red Cross Blood Service NSTOB, Springe, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seltsam</LastName><ForeName>Axel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>German Red Cross Blood Service NSTOB, Springe, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marks</LastName><ForeName>Denese C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Research and Development, Australian Red Cross Blood Service.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transfusion</MedlineTA><NlmUniqueID>0417360</NlmUniqueID><ISSNLinking>0041-1132</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001792" MajorTopicYN="N">Blood Platelets</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058731" MajorTopicYN="N">Blood Safety</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002646" MajorTopicYN="N">Chikungunya virus</DescriptorName><QualifierName UI="Q000528" MajorTopicYN="N">radiation effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000528" MajorTopicYN="N">radiation effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004307" MajorTopicYN="N">Dose-Response Relationship, Radiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057230" MajorTopicYN="N">Limit of Detection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017713" MajorTopicYN="N">Platelet Transfusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012328" MajorTopicYN="N">RNA Viruses</DescriptorName><QualifierName UI="Q000528" MajorTopicYN="Y">radiation effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012398" MajorTopicYN="N">Ross River virus</DescriptorName><QualifierName UI="Q000528" MajorTopicYN="N">radiation effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014466" MajorTopicYN="Y">Ultraviolet Rays</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038301" MajorTopicYN="N">Virus Inactivation</DescriptorName><QualifierName UI="Q000528" MajorTopicYN="Y">radiation effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>09</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>12</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>01</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26926832</ArticleId><ArticleId IdType="doi">10.1111/trf.13519</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li><li>France</li></country></list><tree><noCountry><name sortKey="Faddy, Helen M" sort="Faddy, Helen M" uniqKey="Faddy H" first="Helen M" last="Faddy">Helen M. Faddy</name><name sortKey="Fryk, Jesse J" sort="Fryk, Jesse J" uniqKey="Fryk J" first="Jesse J" last="Fryk">Jesse J. Fryk</name><name sortKey="Hall, Roy A" sort="Hall, Roy A" uniqKey="Hall R" first="Roy A" last="Hall">Roy A. Hall</name><name sortKey="Marks, Denese C" sort="Marks, Denese C" uniqKey="Marks D" first="Denese C" last="Marks">Denese C. Marks</name><name sortKey="Prow, Natalie A" sort="Prow, Natalie A" uniqKey="Prow N" first="Natalie A" last="Prow">Natalie A. Prow</name><name sortKey="Watterson, Daniel" sort="Watterson, Daniel" uniqKey="Watterson D" first="Daniel" last="Watterson">Daniel Watterson</name><name sortKey="Young, Paul R" sort="Young, Paul R" uniqKey="Young P" first="Paul R" last="Young">Paul R. Young</name></noCountry><country name="Allemagne"><noRegion><name sortKey="Tolksdorf, Frank" sort="Tolksdorf, Frank" uniqKey="Tolksdorf F" first="Frank" last="Tolksdorf">Frank Tolksdorf</name></noRegion><name sortKey="Gravemann, Ute" sort="Gravemann, Ute" uniqKey="Gravemann U" first="Ute" last="Gravemann">Ute Gravemann</name><name sortKey="Seltsam, Axel" sort="Seltsam, Axel" uniqKey="Seltsam A" first="Axel" last="Seltsam">Axel Seltsam</name></country><country name="France"><noRegion><name sortKey="Sumian, Chryslain" sort="Sumian, Chryslain" uniqKey="Sumian C" first="Chryslain" last="Sumian">Chryslain Sumian</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003209 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 003209 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:26926832
|texte= Inactivation of dengue, chikungunya, and Ross River viruses in platelet concentrates after treatment with ultraviolet C light.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:26926832" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |